["{\n\"step_by_step_thinking\": \"The question asks about the preference for Isosorbide 5-mononitrate. From the provided documents, we know that Isosorbide mononitrate follows dose-linear kinetics after single and multiple doses. Its pharmacokinetic profile is consistent and highly reproducible and is unchanged in the elderly and in patients with coronary artery disease, renal failure, or liver cirrhosis.\",\n\"answer_choice\": \"C\"\n}"]